These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11723369)
41. Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study. Ding M; Fratiglioni L; Johnell K; Santoni G; Fastbom J; Ljungman P; Marengoni A; Qiu C Neurology; 2018 Nov; 91(19):e1732-e1740. PubMed ID: 30305443 [TBL] [Abstract][Full Text] [Related]
42. [Self and informant perception of clinical manifestations of Alzheimer dementia: results of a structured interview (CAMDEX)]. Förstl H; Geiger-Kabisch C; Sattel H; Besthorn C; Schreiter-Gasser U; Abrahams CM; Biedert S Fortschr Neurol Psychiatr; 1996 Jun; 64(6):228-33. PubMed ID: 8766996 [TBL] [Abstract][Full Text] [Related]
43. [Application of the Brazilian version of the CDR scale in samples of dementia patients]. Maia AL; Godinho C; Ferreira ED; Almeida V; Schuh A; Kaye J; Chaves ML Arq Neuropsiquiatr; 2006 Jun; 64(2B):485-9. PubMed ID: 16917624 [TBL] [Abstract][Full Text] [Related]
44. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Román GC; Tatemichi TK; Erkinjuntti T; Cummings JL; Masdeu JC; Garcia JH; Amaducci L; Orgogozo JM; Brun A; Hofman A Neurology; 1993 Feb; 43(2):250-60. PubMed ID: 8094895 [TBL] [Abstract][Full Text] [Related]
45. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. Ballard C; Patel A; Oyebode F; Wilcock G Age Ageing; 1996 May; 25(3):209-13. PubMed ID: 8670554 [TBL] [Abstract][Full Text] [Related]
46. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Lopez OL; Larumbe MR; Becker JT; Rezek D; Rosen J; Klunk W; DeKosky ST Neurology; 1994 Jul; 44(7):1240-5. PubMed ID: 8035923 [TBL] [Abstract][Full Text] [Related]
47. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Liu CK; Lai CL; Tai CT; Lin RT; Yen YY; Howng SL Neurology; 1998 Jun; 50(6):1572-9. PubMed ID: 9633696 [TBL] [Abstract][Full Text] [Related]
48. [Dementia screening in routine clinical practice. A comparative analysis of MMSE, SIDAM and ADAS]. Burkart M; Heun R; Maier W; Benkert O Nervenarzt; 1998 Nov; 69(11):983-90. PubMed ID: 9859120 [TBL] [Abstract][Full Text] [Related]
49. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests. Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860 [TBL] [Abstract][Full Text] [Related]
50. Differential validity of psychometric tests in dementia of the Alzheimer type. Ihl R; Frölich L; Dierks T; Martin EM; Maurer K Psychiatry Res; 1992 Nov; 44(2):93-106. PubMed ID: 1480682 [TBL] [Abstract][Full Text] [Related]
51. The diagnosis of vascular dementia in the light of the new criteria. Amar K; Wilcock GK; Scott M Age Ageing; 1996 Jan; 25(1):51-5. PubMed ID: 8670529 [TBL] [Abstract][Full Text] [Related]
52. Alzheimer's disease: correlational analysis of three screening tests and three behavioral scales. Villardita C; Lomeo C Acta Neurol Scand; 1992 Dec; 86(6):603-8. PubMed ID: 1481648 [TBL] [Abstract][Full Text] [Related]
53. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese. Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639 [TBL] [Abstract][Full Text] [Related]
54. A survey of dementia in the Canberra population: experience with ICD-10 and DSM-III-R criteria. Henderson AS; Jorm AF; Mackinnon A; Christensen H; Scott LR; Korten AE; Doyle C Psychol Med; 1994 May; 24(2):473-82. PubMed ID: 8084942 [TBL] [Abstract][Full Text] [Related]
55. Prestroke cognitive decline in africans: Prevalence, predictors and association with poststroke dementia. Ojagbemi A; Bello T; Owolabi M; Baiyewu O J Neurol Sci; 2021 Oct; 429():117619. PubMed ID: 34425399 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Canning SJ; Leach L; Stuss D; Ngo L; Black SE Neurology; 2004 Feb; 62(4):556-62. PubMed ID: 14981170 [TBL] [Abstract][Full Text] [Related]
57. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Rockwood K; Davis H; MacKnight C; Vandorpe R; Gauthier S; Guzman A; Montgomery P; Black S; Hogan DB; Kertesz A; Bouchard R; Feldman H Can J Neurol Sci; 2003 Aug; 30(3):237-43. PubMed ID: 12945949 [TBL] [Abstract][Full Text] [Related]
58. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
59. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Smith T; Gildeh N; Holmes C Can J Psychiatry; 2007 May; 52(5):329-32. PubMed ID: 17542384 [TBL] [Abstract][Full Text] [Related]